Company intelligence / Profile preview

CellChorus

South San Francisco, California, United States

Ownership: Private
Employees: ~4
Development stage: Commercial

Overview

CellChorus offers the TIMING platform for dynamic single-cell functional analysis using AI-powered time-lapse imaging. Their technology is commercially available as a service and has been featured in over 20 peer-reviewed publications. It is used by leading biopharma companies to accelerate discovery and development of cell therapies, antibodies, vaccines, and other novel therapies by providing high-content data on individual immune cell function over time. The company recently received an NIH SBIR Fast Track grant to further develop application-specific kits for immune cell phenotype/function analysis.

Therapeutic areas: Other
Modalities: Platform
Industry: Drug Discovery Services

Partnerships

Top 25 biopharma companies developing cell therapies/antibody therapeutics/vaccines are customers

Beyond the preview

Go deeper on CellChorus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CellChorus.

Explore the full profile